Palvella Therapeutics, Inc. (PVLA) vs Trevi Therapeutics, Inc. (TRVI)
Palvella Therapeutics, Inc. and Trevi Therapeutics, Inc. are both Biotechnology companies. Palvella Therapeutics, Inc. and Trevi Therapeutics, Inc. are of similar size ($2.1B and $2.1B). Across the 10 metrics below, Palvella Therapeutics, Inc. leads on 5 and Trevi Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | PVLA | TRVI | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (46.63%) | (19.66%) | (57.72%) |
| Return on assets | (37.70%) | (18.97%) | (49.22%) |
| Return on invested capital | 0.00% | (1,412.11%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack